Company intelligence / Profile preview

Khanu Management

Dortmund, North Rhine‑Westphalia, Germany

Ownership: Private
Development stage: Other

Overview

Khanu Management is a German life sciences investment manager that manages KHAN Technology Transfer Funds I and II, early‑stage venture funds that back innovative drug discovery projects and spin‑outs from European academia, particularly Max Planck Institutes, typically at discovery, pre‑clinical, and early clinical stages.[1][4][5]

Modalities: Small moleculeMonoclonal antibodyAntibodyBiologic
Industry: Investors

Partnerships

European Investment Fund (EIF)[4][5]Max Planck Foundation[4][5]Max Planck Society (MPG) / Max Planck Innovation[4][5]Austria Wirtschaftsservice GmbH (aws)[4]Lead Discovery Center (LDC)[1][4][5]wings4innovation (w4i)[4]Akros Pharma[1][5]Thyssen’sche Handelsgesellschaft (THG)[1][5]

Beyond the preview

Go deeper on Khanu Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Khanu Management.

Explore the full profile